(Q30361082)

14 November 2017

Ferric citrate controls phosphorus and delivers iron in patients on dialysis. (English)

1 reference

Collaborative Study Group

14 November 2017

0 references

1 reference

ChEBI release 2020-05-28

ChEBI ID

144421

author

20

object named as

Collaborative Study Group

1 reference

14 November 2017

Julia B Lewis

1

1 reference

14 November 2017

Mohammed Sika

2

1 reference

14 November 2017

Mark J Koury

3

1 reference

14 November 2017

Peale Chuang

4

1 reference

14 November 2017

Gerald Schulman

5

1 reference

14 November 2017

Mark T Smith

6

1 reference

14 November 2017

Frederick C Whittier

7

1 reference

14 November 2017

Douglas R Linfert

8

1 reference

14 November 2017

Claude M Galphin

9

1 reference

14 November 2017

Balaji P Athreya

10

1 reference

14 November 2017

A Kaldun Kaldun Nossuli

11

1 reference

14 November 2017

Ingrid J Chang

12

1 reference

14 November 2017

Samuel S Blumenthal

13

1 reference

14 November 2017

John Manley

14

1 reference

14 November 2017

Steven Zeig

15

1 reference

14 November 2017

Kotagal S Kant

16

1 reference

14 November 2017

Juan Jose Olivero

17

1 reference

14 November 2017

Tom Greene

18

1 reference

14 November 2017

Jamie P Dwyer

19

1 reference

14 November 2017

24 July 2014

1 reference

Journal of the American Society of Nephrology

14 November 2017

1 reference

14 November 2017

26

1 reference

14 November 2017

2

1 reference

14 November 2017

493-503

1 reference

Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Effect of aggressively driven intravenous iron therapy on infectious complications in end-stage renal disease patients on maintenance hemodialysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Iron overload in human disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Iron supplementation to treat anemia in patients with chronic kidney disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Oral phosphate binders in patients with kidney failure

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Serum phosphorus levels associate with coronary atherosclerosis in young adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Accumulation of metals and minerals from phosphate binders

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Iron requirements in hemodialysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

A randomized controlled study of iron supplementation in patients treated with erythropoietin

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310662

Sevelamer reduces the efficacy of many other drugs

26 November 2018

1 reference

12 December 2020

Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients

1 reference

12 December 2020

The DOPPS Practice Monitor for US dialysis care: trends through December 2011

1 reference

12 December 2020

Effects of erythropoietin therapy on iron absorption in chronic renal failure

1 reference

12 December 2020

Gatekeeping strategies for clinical trials that do not require all primary effects to be significant

1 reference

12 December 2020

Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study

1 reference

12 December 2020

New phosphate binding agents: ferric compounds

1 reference

12 December 2020

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2014020212

1 reference

14 November 2017

1 reference

14 November 2017

PubMed publication ID

25060056

1 reference